Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors

Liver Transplantation

Volumn 9, Issue 10, 2003, Pages 1028-1035

  Gaglio, Paul J ^a   Malireddy, Srikar ^a   Levitt, Brian S ^a   Lapointe Rudow, Dianne ^a   Lefkowitch, Jay ^a   Kinkhabwala, Milan ^a   Russo, Mark W ^a   Emond, Jean C ^a   Brown Jr , Robert S ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CYCLOSPORIN; CYCLOSPORIN A; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CADAVER DONOR; CHOLESTASIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION;

EID: 0142248361     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50211     Document Type: Article

References (30)

1. Berenguer M, Lopez-Labrador FX, Wright TT. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.
2. Prieto M, Berunguer M, Rayon M, Cordoba J, Arguello L, Carasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection after transplantation: Relationship with rejection episodes. Hepatology 1999;29:250-256.
3. Test G, Crippen JS, Netto GJ, Goldstein RM, Jennings LW, Berkic BS, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000;6: 553-561.
4. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV related fibrosis progression after liver transplantation: Increase in recent years. J Hepatol 2000;32:673-684.
5. Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, et al. Timing and severity of hepatitis C recurrence after liver transplantation as predictors of long term allograft injury. Transplantation 1998;65:1178-1182.
6. Sanchez-Fueyos A, Restrepo J-C, Quinto L, Bruguera M, Grande L, Sanchez Tapia JM, et al. Impact of the recurrence of hepatitis C infection after liver transplantation on the long term viability of the graft. Transplantation 2002;73:56-63.
7. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
8. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
9. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: Results of the National Institute of Diabetes and Digestive and Kidney Disease Liver Transplantation Database. Liver Transpl Surg 1999; 5(suppl):S107-114.
10. Gane E, Portman B, Naoumov N, Smith HM, Underhill JA, Donaldson PT, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
11. Berenguer M, Prieto M, Rayon J, Mora J, Pastor M, Vicente O, et al. Natural history of clinically compensated hepatitis C virus related graft cirrhosis after liver transplantation. Hepatology 2000;32:852-858.
12. Charlton M, Seaberg E, Weisner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival after liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
13. McGaughan GW, Zekry A. Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection. Transpl Infect Dis 2000;2: 166-168.
14. Delladetsima JK, Boletis JN, Makris F, Psichogiou M, Kostakis A, Hatzakis A. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 1999;5:294-300.
15. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
16. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of HCV internal ribosomal entry site - directed translation. Gastroenterology 2000;118:152-162.
17. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 1998;4:15-21.
18. Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, et al. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related injury. Liver Transpl 2002;8:292-301.
19. Demetris AJ, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, et al. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002;74: 1290-1296.
20. Everson GT. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 2002;8:S19-27.
21. Kinkhabwala MM, Guarrera JV, Leno R, Brown RS, Prowda J, Kapur S, et al. Outflow reconstruction in right hepatic live donor liver transplantation. Surgery 2003;133:243-250.
22. McCaughan GW, Zekry A. Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 2002;8:S7-13.
23. Berenguer M, Rayon M, Prieto M, Aquilera V, Nicolai D, Ortiz V, et al. Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 2001;7:790-796.
24. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
25. Menon K, Poterucha J, El-Amin O, Burgart L, Kremers W, Rosen C, et al. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficiacy. Liver Transpl 2002;8:623-629.
26. Gopal D, Rabkin J, Berk B, Corless C, Chou S, Olyaei A, et al. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 2001;7:181-190.
27. Shakil A, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, et al. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology 2002;36:1253-1258.
28. Rosen H, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998;66:1612-1616.
29. Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, et al. Retransplantation for late liver graft failure: Predictors of mortality. Liver Transpl 2000;6:174-179.
30. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long term outcomes of hepatitis C infection after liver transplantation. N Engl J Med 1996;334: 815-821.